Intrauterine Intervention for the Treatment of Fetal Growth Restriction

A-M Spiroski, M H Oliver, J E Harding

  • 1Liggins Institute, University of Auckland, Private Bag 92019, Auckland, New Zealand. f.bloomfield@auckland.ac.nz.

Insights

Fetal growth restriction (FGR) increases risks for newborns. Intrauterine interventions show promise for improving fetal growth, survival, and long-term health outcomes.

Area of Science:

  • Perinatal Medicine
  • Developmental Biology
  • Neonatology

Background:

  • Fetal growth restriction (FGR) is linked to higher rates of fetal/neonatal death and morbidity.
  • FGR infants face postnatal complications, increasing risks for adult chronic diseases.
  • Current interventions for FGR lack effectiveness in improving perinatal survival or intrauterine growth.

Purpose of the Study:

  • To explore the potential of intrauterine interventions for FGR.
  • To assess if intrauterine interventions can improve fetal growth and long-term outcomes.
  • To mitigate risks associated with postnatal growth acceleration in FGR infants.

Main Methods:

  • This study is a review of current literature and clinical approaches to FGR.
  • Analysis of the potential benefits and risks of intrauterine versus postnatal interventions.
  • Evaluation of the impact of nutritional and growth support in utero.

Main Results:

  • No effective clinical interventions currently exist to improve perinatal survival or intrauterine growth in FGR.
  • Postnatal growth acceleration in FGR may increase risks of metabolic dysregulation and chronic disease.
  • Intrauterine interventions could potentially reduce mortality and improve long-term outcomes.

Conclusions:

  • Intrauterine interventions offer a potential strategy to improve outcomes for fetuses with FGR.
  • Improving fetal nutrition and growth in utero may decrease preterm delivery and postnatal risks.
  • Further research into intrauterine interventions is warranted to enhance FGR infant health.